Aptinyx Inc.
APTXDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001674365
Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Aptinyx Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −5 vs. Q3 2022
- Shares held
- 29.1M
- −2.01M (−6.5%) vs. Q3 2022
- Total value
- $8.33M
- −$3.15M (−27.5%) vs. Q3 2022
- New holders
- 4
- 6 more added
- Sold out
- 9
- 11 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $7.00K |
| Q2 2023 | 3 | $24.0K |
| Q1 2023 | 32 | $2.44M |
| Q4 2022 | 35 | $8.33M |
| Q3 2022 | 40 | $11.5M |
| Q2 2022 | 41 | $19.1M |
| Q1 2022 | 60 | $81.3M |
| Q4 2021 | 49 | $92.4M |
| Q3 2021 | 50 | $79.8M |
| Q2 2021 | 66 | $99.8M |
| Q1 2021 | 70 | $122.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aptinyx Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 110 | $0 | 0.00% | +110 | New |
| UBS Group AG | 462 | $134 | 0.00% | −26,933−98.3% | Reduced |
| Wells Fargo & Company | 767 | $219 | 0.00% | −494−39.2% | Reduced |
| Bank of America Corp | 904 | $258 | 0.00% | −146−13.9% | Reduced |
| Allworth Financial LP | 1,000 | $285 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 3,000 | $855 | 0.00% | −7,000−70.0% | Reduced |
| Morgan Stanley | 7,927 | $2.26K | 0.00% | −10.0% | Reduced |
| Calamos Wealth Management LLC | 10,000 | $2.85K | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 10,000 | $2.85K | 0.00% | +10,000 | New |
| Blair William & Co | 19,877 | $5.67K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,973 | $7.61K | 0.00% | +25,973 | New |
| Tower Research Capital LLC (TRC) | 27,095 | $8.00K | 0.00% | +27,095 | New |
| Group One Trading, L.P. | 30,653 | $8.98K | 0.00% | −16,981−35.6% | Reduced |
| Raymond James & Associates | 46,075 | $13.1K | 0.00% | −27,950−37.8% | Reduced |
| Cetera Advisor Networks LLC | 51,000 | $14.6K | 0.00% | +11,000+27.5% | Added |
| Bank of New York Mellon Corp | 80,858 | $23.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 103,039 | $29.4K | 0.00% | −2,732−2.6% | Reduced |
| Northwestern University | 109,280 | $32.0K | 0.03% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 126,777 | $35.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 138,251 | $40.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 150,068 | $42.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 174,225 | $49.7K | 0.00% | −10,300−5.6% | Reduced |
| Meridian Wealth Management, LLC | 192,000 | $54.8K | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 212,900 | $60.7K | 0.00% | −9,300−4.2% | Reduced |
| Geode Capital Management, LLC | 377,582 | $110.0K | 0.00% | −832−0.2% | Reduced |
| Point72 Asset Management, L.P. | 410,416 | $117.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 618,226 | $176.0K | 0.00% | +77,200+14.3% | Added |
| BlackRock Inc. | 687,192 | $196.1K | 0.00% | +1,330+0.2% | Added |
| Millennium Management LLC | 1,333,622 | $391.0K | 0.00% | +129,635+10.8% | Added |
| Vanguard Group Inc | 1,815,780 | $518.0K | 0.00% | +8320.0% | Added |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $537.3K | 0.03% | 00.0% | Unchanged |
| Adams Street Partners LLC | 5,395,996 | $1.56M | 0.52% | 00.0% | Unchanged |
| Artal Group S.A. | 6,116,493 | $1.75M | 0.10% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $2.54M | 0.28% | 00.0% | Unchanged |
| HBK Sorce Advisory LLC | 52,000 | – | – | +26,000+100.0% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,954,698−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −124,041−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −75,283−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,806−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −10,901−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,873−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,083−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −432−100.0% | Sold out |
| Navigation Wealth Management, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |